Cellectar Biosciences Inc (CLRB)
0.2535
-0.02
(-8.05%)
USD |
NASDAQ |
Dec 24, 16:00
Cellectar Biosciences Free Cash Flow: -46.57M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
Ionis Pharmaceuticals Inc | -374.21M |
Ligand Pharmaceuticals Inc | 6.968M |
Revance Therapeutics Inc | -194.91M |
Zymeworks Inc | -59.09M |
Applied Therapeutics Inc | -81.84M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -9.167M |
Cash from Financing (Quarterly) | 17.56M |
Free Cash Flow Per Share (Quarterly) | -0.2304 |
Free Cash Flow Yield | -604.2% |